Primary plasma cell leukemia: autologous stem cell transplant in an era of novel induction drugs
Primary plasma cell leukemia: autologous stem cell transplant in an era of novel induction drugs
About this item
Full title
Author / Creator
Gowda, Lohith , Shah, Mithun , Badar, Ifra , Bashir, Qaiser , Shah, Nina , Patel, Krina , Kanagal-Shamanna, Rashmi , Mehta, Rohtesh , Weber, Donna M. , Lee, Hans C. , Manasanch, Elisabet E. , Shah, Abdul , Thomas, Sheeba K. , Parmar, Simrit , Nieto, Yago , Orlowski, Robert Z. , Champlin, Richard and Qazilbash, Muzaffar H.
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Primary plasma cell leukemia (pPCL) is a rare and aggressive variant of multiple myeloma (MM) with poor long-term survival after cytotoxic chemotherapy. Many novel drugs have revolutionized the treatment algorithms for MM. The impact of targeted therapy, both pre- and post-autologous stem cell transplant (auto-HCT) remains an area of ongoing intere...
Alternative Titles
Full title
Primary plasma cell leukemia: autologous stem cell transplant in an era of novel induction drugs
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8393277
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8393277
Other Identifiers
ISSN
0268-3369
E-ISSN
1476-5365
DOI
10.1038/s41409-018-0392-1
